Surface Oncology Inc. (NASDAQ: SURF) established initial surge of 2.04% at $9.50, as the Stock market unbolted on February 19, 2021. During the day, the stock rose to $9.88 and sunk to $9.34 before settling in for the price of $9.31 at the close. Taking a more long-term approach, SURF posted a 52-week range of $1.38-$14.40.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -495.10%. This publicly-traded company’s shares outstanding now amounts to $40.01 million, simultaneously with a float of $36.17 million. The organization now has a market capitalization sitting at $378.67 million. At the time of writing, stock’s 50-day Moving Average stood at $10.64, while the 200-day Moving Average is $7.43.
While finding the extent of efficiency of the company that is accounted for 49 employees. It has generated 313,469 per worker during the last fiscal year. Meanwhile, its income per employee was -1,118,143. The stock had 46.62 Receivables turnover and 0.10 Total Asset turnover. For the Profitability, stocks operating margin was -373.48 and Pretax Margin of -356.70.
Surface Oncology Inc. (SURF) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Surface Oncology Inc. industry. Surface Oncology Inc.’s current insider ownership accounts for 1.10%, in contrast to 59.80% institutional ownership. According to the most recent insider trade that took place on Feb 16, this organization’s Chief Medical Officer sold 1,000 shares at the rate of 11.35, making the entire transaction reach 11,350 in total value, affecting insider ownership by 88,000. Preceding that transaction, on Feb 08, Company’s Chief Executive Officer sold 2,500 for 12.50, making the whole transaction’s value amount to 31,250. This particular insider is now the holder of 262,000 in total.
Surface Oncology Inc. (SURF) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2020, it has been observed that the corporation posted -$0.39 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.39) by $0. This company achieved a net margin of -356.70 while generating a return on equity of -68.69. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.23 per share during the current fiscal year.
Surface Oncology Inc.’s EPS decrease for this current 12-month fiscal period is -495.10% and is forecasted to reach -0.75 in the upcoming year.
Surface Oncology Inc. (NASDAQ: SURF) Trading Performance Indicators
Let’s observe the current performance indicators for Surface Oncology Inc. (SURF). It’s Quick Ratio in the last reported quarter now stands at 7.90. The Stock has managed to achieve an average true range (ATR) of 0.95. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.71.
In the same vein, SURF’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.68, a figure that is expected to reach -0.05 in the next quarter, and analysts are predicting that it will be -0.75 at the market close of one year from today.
Technical Analysis of Surface Oncology Inc. (SURF)
Now, what If we examine the latest scores posted by [Surface Oncology Inc., SURF]. During the last 5-days, its volume was lower the volume of 1.25 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 5.55% While, its Average True Range was 0.88.
Raw Stochastic average of Surface Oncology Inc. (SURF) in the period of the previous 100 days is set at 39.58%, which indicates a major rise in contrast to 5.90% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 78.19% that was lower than 100.03% volatility it exhibited in the past 100-days period.